S&P 500   3,380.20 (+1.40%)
DOW   27,983.62 (+1.07%)
QQQ   270.08 (+1.84%)
AAPL   445.21 (+1.76%)
MSFT   207.45 (+2.00%)
FB   262.67 (+2.55%)
GOOGL   1,505.47 (+1.68%)
AMZN   3,142.00 (+1.99%)
NVDA   444.95 (+2.52%)
CGC   16.97 (+0.12%)
BABA   249.35 (+0.37%)
TSLA   1,477.83 (+7.53%)
GE   6.73 (-0.74%)
MU   48.02 (+0.54%)
AMD   79.93 (+3.97%)
T   30.30 (+0.33%)
F   7.19 (-0.55%)
ACB   9.91 (-1.10%)
GILD   68.81 (+1.04%)
NFLX   477.27 (+2.21%)
DIS   132.42 (+1.48%)
BAC   27.10 (+0.67%)
BA   178.29 (-1.02%)
S&P 500   3,380.20 (+1.40%)
DOW   27,983.62 (+1.07%)
QQQ   270.08 (+1.84%)
AAPL   445.21 (+1.76%)
MSFT   207.45 (+2.00%)
FB   262.67 (+2.55%)
GOOGL   1,505.47 (+1.68%)
AMZN   3,142.00 (+1.99%)
NVDA   444.95 (+2.52%)
CGC   16.97 (+0.12%)
BABA   249.35 (+0.37%)
TSLA   1,477.83 (+7.53%)
GE   6.73 (-0.74%)
MU   48.02 (+0.54%)
AMD   79.93 (+3.97%)
T   30.30 (+0.33%)
F   7.19 (-0.55%)
ACB   9.91 (-1.10%)
GILD   68.81 (+1.04%)
NFLX   477.27 (+2.21%)
DIS   132.42 (+1.48%)
BAC   27.10 (+0.67%)
BA   178.29 (-1.02%)
S&P 500   3,380.20 (+1.40%)
DOW   27,983.62 (+1.07%)
QQQ   270.08 (+1.84%)
AAPL   445.21 (+1.76%)
MSFT   207.45 (+2.00%)
FB   262.67 (+2.55%)
GOOGL   1,505.47 (+1.68%)
AMZN   3,142.00 (+1.99%)
NVDA   444.95 (+2.52%)
CGC   16.97 (+0.12%)
BABA   249.35 (+0.37%)
TSLA   1,477.83 (+7.53%)
GE   6.73 (-0.74%)
MU   48.02 (+0.54%)
AMD   79.93 (+3.97%)
T   30.30 (+0.33%)
F   7.19 (-0.55%)
ACB   9.91 (-1.10%)
GILD   68.81 (+1.04%)
NFLX   477.27 (+2.21%)
DIS   132.42 (+1.48%)
BAC   27.10 (+0.67%)
BA   178.29 (-1.02%)
S&P 500   3,380.20 (+1.40%)
DOW   27,983.62 (+1.07%)
QQQ   270.08 (+1.84%)
AAPL   445.21 (+1.76%)
MSFT   207.45 (+2.00%)
FB   262.67 (+2.55%)
GOOGL   1,505.47 (+1.68%)
AMZN   3,142.00 (+1.99%)
NVDA   444.95 (+2.52%)
CGC   16.97 (+0.12%)
BABA   249.35 (+0.37%)
TSLA   1,477.83 (+7.53%)
GE   6.73 (-0.74%)
MU   48.02 (+0.54%)
AMD   79.93 (+3.97%)
T   30.30 (+0.33%)
F   7.19 (-0.55%)
ACB   9.91 (-1.10%)
GILD   68.81 (+1.04%)
NFLX   477.27 (+2.21%)
DIS   132.42 (+1.48%)
BAC   27.10 (+0.67%)
BA   178.29 (-1.02%)
Log in

NASDAQ:CMECME Group Stock Price, Forecast & News

$170.66
+2.54 (+1.51 %)
(As of 08/12/2020 10:57 AM ET)
Add
Compare
Today's Range
$169.67
Now: $170.66
$172.22
50-Day Range
$162.01
MA: $166.85
$175.52
52-Week Range
$131.80
Now: $170.66
$225.36
Volume23,860 shs
Average Volume2.12 million shs
Market Capitalization$61.20 billion
P/E Ratio25.74
Dividend Yield2.06%
Beta0.3
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products. The company executes trade through its electronic trading platforms, open outcry, and privately negotiated transactions; and provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services. It also offers transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, analytics, and regulatory reporting. In addition, the company provides a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Read More
CME Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.52 out of 5 stars


Industry, Sector and Symbol

Industry Security & commodity brokers, dealers, exchanges & services
Sub-IndustrySpecialized Finance
SectorFinance
Current SymbolNASDAQ:CME
CUSIP12572Q10
Phone312-930-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.87 billion
Cash Flow$8.30 per share
Book Value$73.18 per share

Profitability

Net Income$2.12 billion

Miscellaneous

Employees4,360
Market Cap$61.20 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$170.66
+2.54 (+1.51 %)
(As of 08/12/2020 10:57 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CME News and Ratings via Email

Sign-up to receive the latest news and ratings for CME and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CME Group (NASDAQ:CME) Frequently Asked Questions

How has CME Group's stock been impacted by COVID-19 (Coronavirus)?

CME Group's stock was trading at $194.6750 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CME stock has decreased by 12.3% and is now trading at $170.66.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of CME Group?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 3 sell ratings, 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for CME Group
.

When is CME Group's next earnings date?

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for CME Group
.

How were CME Group's earnings last quarter?

CME Group Inc (NASDAQ:CME) released its quarterly earnings data on Wednesday, July, 29th. The financial services provider reported $1.63 EPS for the quarter, topping the Zacks' consensus estimate of $1.62 by $0.01. The financial services provider earned $1.18 billion during the quarter, compared to analyst estimates of $1.20 billion. CME Group had a return on equity of 9.93% and a net margin of 46.39%. The company's revenue for the quarter was down 7.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.76 EPS.
View CME Group's earnings history
.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group declared a quarterly dividend on Thursday, August 6th. Shareholders of record on Thursday, September 10th will be paid a dividend of $0.85 per share on Friday, September 25th. This represents a $3.40 dividend on an annualized basis and a dividend yield of 1.99%. The ex-dividend date is Wednesday, September 9th.
View CME Group's dividend history
.

What price target have analysts set for CME?

16 Wall Street analysts have issued twelve-month target prices for CME Group's stock. Their forecasts range from $130.00 to $227.00. On average, they anticipate CME Group's share price to reach $188.27 in the next twelve months. This suggests a possible upside of 10.3% from the stock's current price.
View analysts' price targets for CME Group
.

Has CME Group been receiving favorable news coverage?

Media stories about CME stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CME Group earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave media headlines about the financial services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future.
View the latest news about CME Group
.

Are investors shorting CME Group?

CME Group saw a decline in short interest in the month of February. As of February 15th, there was short interest totaling 5,700,000 shares, a decline of 12.2% from the January 31st total of 6,490,000 shares. Based on an average daily volume of 1,460,000 shares, the days-to-cover ratio is currently 3.9 days. Approximately 1.6% of the shares of the stock are sold short.
View CME Group's Short Interest
.

Who are some of CME Group's key competitors?

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), Paypal (PYPL), Visa (V), Walt Disney (DIS), Alibaba Group (BABA), Cisco Systems (CSCO), Intel (INTC), Netflix (NFLX) and Boeing (BA).

Who are CME Group's key executives?

CME Group's management team includes the following people:
  • Mr. Terrence A. Duffy, Chairman & CEO (Age 61)
  • Mr. Bryan Thomas Durkin, Pres (Age 58)
  • Mr. John W. Pietrowicz M.B.A., CPA, Sr. MD & CFO (Age 54)
  • Ms. Julie Holzrichter, Sr. MD & COO (Age 50)
  • Mr. Sean P. Tully, Sr. MD and Global Head of Financial & OTC Products (Age 55)

What is CME Group's stock symbol?

CME Group trades on the NASDAQ under the ticker symbol "CME."

Who are CME Group's major shareholders?

CME Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include California Public Employees Retirement System (0.75%), Thornburg Investment Management Inc. (0.55%), Cantillon Capital Management LLC (0.52%), Sumitomo Mitsui Trust Holdings Inc. (0.45%), Jackson Square Partners LLC (0.32%) and Russell Investments Group Ltd. (0.25%). Company insiders that own CME Group stock include Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends for CME Group
.

Which major investors are selling CME Group stock?

CME stock was sold by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, Viking Global Investors LP, Macquarie Group Ltd., Toronto Dominion Bank, Russell Investments Group Ltd., New York State Common Retirement Fund, AKO Capital LLP, and Sumitomo Mitsui Trust Holdings Inc.. Company insiders that have sold CME Group company stock in the last year include Daniel R Glickman, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Martin J Gepsman, Ronald A Pankau, Sean Tully, Terrence A Duffy, and Timothy S Bitsberger.
View insider buying and selling activity for CME Group
.

Which major investors are buying CME Group stock?

CME stock was acquired by a variety of institutional investors in the last quarter, including First Trust Advisors LP, California Public Employees Retirement System, Robeco Institutional Asset Management B.V., SG Americas Securities LLC, Thornburg Investment Management Inc., Rafferty Asset Management LLC, Natixis Advisors L.P., and Troy Asset Management Ltd.
View insider buying and selling activity for CME Group
.

How do I buy shares of CME Group?

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CME Group's stock price today?

One share of CME stock can currently be purchased for approximately $170.66.

How big of a company is CME Group?

CME Group has a market capitalization of $61.20 billion and generates $4.87 billion in revenue each year. The financial services provider earns $2.12 billion in net income (profit) each year or $6.80 on an earnings per share basis. CME Group employs 4,360 workers across the globe.

What is CME Group's official website?

The official website for CME Group is www.cmegroup.com.

How can I contact CME Group?

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.